NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1720442650
Verify on CMS → Ahmed Alshaban
Hematology & Oncology Physician in Sedro Woolley, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
251
Medicare Part D claims · 65 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.3/100
▲ 8 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Ahmed Alshaban reported a CMS MIPS final score of 91.3/100 - above the 83.1 national average - and filed 251 Medicare Part D claims in 2023.
- 91.3/100
- MIPS score · +8 vs avg
- 251
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ahmed Alshaban's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ahmed Alshaban sits
This provider among hematology & oncology physician peers
Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ahmed Alshaban writes more Part D claims than 20% of them and scores higher on MIPS quality than 64% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Ahmed Alshaban. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Ahmed Alshaban practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ahmed Alshaban?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
251 70% vs specialty avg
MIPS final score
91.3/100 8.2 pts vs avg
Specialty distribution in Washington
How Hematology & Oncology Physician compares to other specialties among Washington providers
Medicare quality performance, MIPS
Ahmed Alshaban's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 91.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) - 91.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ahmed Alshaban appears in the CMS NPPES registry as a Hematology & Oncology Physician provider at 1990 HOSPITAL DR STE 100, Sedro Woolley, WA, 98284, with a listed phone of (360) 856-8800. NPI 1720442650 was issued on 04/06/2016.
Medicare Part D records for calendar year 2023 show 251 prescription claims written by this provider, covering 65 Medicare beneficiaries and totaling roughly $326K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 7.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.3/100 for the 2023 performance year (Quality 84.2), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1720442650 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Gender | Male |
| NPI Issued | 04/06/2016 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.3282
Final Score
Avg: 83.1
84.233
Quality
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Ahmed Alshaban bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Optum Care Washington PLLC
Anacortes, WA
The Polyclinic PLLC
Seattle, WA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Ahmed Alshaban. To verify Ahmed Alshaban's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Ahmed Alshaban - brand share 14.0%
Hematology & Oncology Physician average
14% brand-name claims vs 86% generic, on 251 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
251
Total Claims
$326K
Total Drug Cost
65
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 362
- Total Day Supply
- 8,726
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $323K
- Generic Drug Cost
- $3K
- Opioid Claims
- 19 (7.6% rate)
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.73
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ahmed Alshaban prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prochlorperazine M…
Prochlorperazine Maleate
30 claims
- Letrozole
Letrozole
26 claims
- Dexamethasone
Dexamethasone
16 claims
- Acyclovir
Acyclovir
15 claims
- Ondansetron Hcl
Ondansetron Hcl
14 claims
- Eliquis
Eliquis
13 claims
| Drug | Claims |
|---|---|
| Prochlorperazine Maleate | 30 |
| Letrozole | 26 |
| Dexamethasone | 16 |
| Acyclovir | 15 |
| Ondansetron Hcl | 14 |
| Eliquis Apixaban | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Ahmed Alshaban fits within the Hematology & Oncology Physician landscape nationally.
11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Ahmed Alshaban's 251 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Alshaban.
Dr. Farnoush Abar
M.D.
Seattle, WA
Janis Abkowitz
Seattle, WA
Dr. David Aboulafia
MD
Seattle, WA
Dr. Manoj Agarwal
MD, MBA
Seattle, WA
Shirali Agarwal
Seattle, WA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Washington medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Washington
Frequently Asked Questions
What is Ahmed Alshaban's specialty? ▼
Ahmed Alshaban specializes in Hematology & Oncology Physician and practices in Sedro Woolley, Washington.
How much does Ahmed Alshaban prescribe under Medicare Part D? ▼
In 2023, Ahmed Alshaban wrote 251 Medicare Part D claims totaling $326K in drug costs for 65 beneficiaries.
What is Ahmed Alshaban's Medicare quality score? ▼
Ahmed Alshaban has a CMS MIPS Final Score of 91.3/100 (Quality: 84.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Ahmed Alshaban located? ▼
Ahmed Alshaban is located at 1990 HOSPITAL DR STE 100, Sedro Woolley, WA, 98284. Phone: (360) 856-8800.
What is Ahmed Alshaban's NPI number? ▼
Ahmed Alshaban's National Provider Identifier (NPI) is 1720442650, issued on 04/06/2016.
Does Ahmed Alshaban prescribe more brand-name or generic drugs? ▼
Ahmed Alshaban's prescribing is 14% brand-name and 86% generic drugs by claim count, with $323K in brand drug costs.
Does Ahmed Alshaban prescribe opioids? ▼
Yes, Ahmed Alshaban had 19 opioid claims in 2023 with an opioid prescribing rate of 7.6%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Ahmed Alshaban prescribe most often? ▼
Based on 2023 Medicare Part D data, Ahmed Alshaban's most frequently prescribed drugs include Prochlorperazine Maleate, Letrozole, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ahmed Alshaban accept Medicare? ▼
Ahmed Alshaban appears in CMS Medicare data with 251 Part D claims and 65 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ahmed Alshaban's credentials? ▼
Ahmed Alshaban's NPI is 1720442650. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.